Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome)

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 5, 2010, Pages 555-571

  Strassburg, Christian P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

ABCC2; Drug toxicity; Genotyping; Gilbert syndrome; Glucuronidation; Hepatobiliary transport; Jaundice; UGT1A1

Indexed keywords

ATAZANAVIR; BILIRUBIN; COPROPORPHYRIN; INDINAVIR; IRINOTECAN;

BILIRUBIN BLOOD LEVEL; BREAST CANCER; CLINICAL FEATURE; COLORECTAL CANCER; CRIGLER NAJJAR SYNDROME; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DUBIN JOHNSON SYNDROME; GALLSTONE; GENE LOCUS; GENETIC VARIABILITY; GILBERT DISEASE; GLUCURONIDATION; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LINKAGE ANALYSIS; PROGNOSIS; REVIEW; RISK FACTOR; ROTOR SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; URINARY EXCRETION;

EID: 77958083675     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.07.007     Document Type: Article

References (97)

1. G.A. Kullak-Ublick, U. Beuers, and G. Paumgartner Hepatobiliary transport J Hepatol 32 2000 3 18
2. I.N. Dubin, and F.B. Johnson Chronic idiopathic jaundice with unidentified pigment in liver cells: a new clinical entity with 12 cases Medicine 33 1954 155 172
3. H. Sprintz, and R.S. Nelson Persistent nonhemolytic hyperbilirubinemia associated with lipochrome-like pigment in liver cells: report of four cases Ann Internal Med 41 1954 952 961
4. A.T. Nies, and D. Keppler The apical conjugate efflux pump ABCC2 (MRP2) Pflugers Arch 453 2007 643 659
5. G. Jedlitschky, U. Hoffmann, and H.K. Kroemer Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition Expert Opin Drug Metab Toxicol 2 2006 351 366
6. M. Hrebicek, T. Jirasek, and H. Hartmannova Rotor-type hyperbilirubinaemia has no defect in the canalicular bilirubin export pump Liver Int 27 2007 485 491
7. V. Keitel, A.T. Nies, and M. Brom A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2) Am J Physiol Gastrointest Liver Physiol 284 2003 G165 G174
8. M. Nambu, and T. Namihisa Hepatic transport of serum bilirubin, bromsulfophthalein, and indocyanine green in patients with congenital non-hemolytic hyperbilirubinemia and patients with constitutional indocyanine green excretory defect J Gastroenterol 31 1996 228 236
9. T. Pinos, J.M. Constansa, and A. Palacin A new diagnostic approach to the Dubin-Johnson syndrome Am J Gastroenterol 85 1990 91 93
10. A.B. Rotor, L. Manahan, and A. Florentin Familial nonhemolytic jaundice with direct van den Bergh reaction Acta Med Phil 5 1948
11. P. Berthelot, and D. Dhumeaux New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias Gut 19 1978 474 480
12. H. Abe, and K. Okuda Biliary excretion of conjugated sulfobromophthalein (BSP) in constitutional conjugated hyperbilirubinemias Digestion 13 1975 272 283
13. C.P. Strassburg Gilbert-Meulengracht's syndrome and pharmacogenetics: is jaundice just the tip of the iceberg? Drug Metab Rev 42 2010 162 175
14. A. Gilbert, and P. Lereboullet La cholamae simple familiale Sem Med 21 1901 241 248
15. I.M. Arias Chronic unconjugated hyperbilirubinemia without signs of overt hemolysis in adolescents and adults J Clin Invest 41 1962 2233 2245
16. C.P. Strassburg, and M.P. Manns Jaundice, genes and promoters J Hepatology 33 2000 476 479
17. J.K. Ritter, J.M. Crawford, and I.S. Owens Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells J Biol Chem 266 1991 1043 1047
18. J.K. Ritter, M.T. Yeatman, and P. Ferreira Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient J Clin Invest 90 1992 150 155
19. P.J. Bosma, J.R. Chowdhury, and C. Bakker The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome N Engl J Med 333 1995 1171 1175
20. P.D. Berk, T.F. Blaschke, and J.G. Waggoner Defective bromosulfophthalein clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome) Gastroenterology 63 1972 472 481
21. J.F. Martin, J.M. Vierling, and A.W. Wolkoff Abnormal hepatic transport of indocyanine green in Gilbert's syndrome Gastroenterology 70 1976 385 391
22. N. Carulli, M. Ponz de Leon, and E. Mauro Alteration of drug metabolism in Gilbert's syndrome Gut 17 1976 581 587
23. A.F. Macklon, R.L. Savage, and M.D. Rawlins Gilbert's syndrome and drug metabolism Clin Pharmacokinet 4 1979 223 232
24. S.D. Campbell, S.M. de Morais, and J.J. Xu Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia Chem Biol Interact 150 2004 179 187
25. A.D. Johnson, M. Kavousi, and A.V. Smith Genome-wide association meta-analysis for total serum bilirubin levels Hum Mol Genet 18 2009 2700 2710
26. C.P. Strassburg, S. Kalthoff, and U. Ehmer Variability and function of family 1 uridine-5′-diphosphate glucuronosyltransferases (UGT1A) Crit Rev Clin Lab Sci 45 2008 485 530
27. N. Nguyen, J.A. Bonzo, and S. Chen Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease J Biol Chem 283 2008 7901 7911
28. P.J. Bosma, B. Goldhoorn, and R.P. Oude Elferink A mutation in bilirubin uridine 5′-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II Gastroenterology 105 1993 216 220
29. J.K. Ritter, M.T. Yeatman, and C. Kaiser A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase J Biol Chem 268 1993 23573 23579
30. R.H. Tukey, and C.P. Strassburg Human UDP-glucuronosyltransferases: metabolism, expression, and disease Annu Rev Pharmacol Toxicol 40 2000 581 616
31. J.L. Fang, and P. Lazarus Correlation between the UDP- glucuronosyltransferase (UGT1A1) TATAA box polymorphism and carcinogen detoxification phenotype: significantly decreased glucuronidating activity against benzo(a)pyrene-7,8-dihydrodiol(-) in liver microsomes from subjects with the UGT1A128 variant Cancer Epidemiol Biomarkers Prev 13 2004 102 109
32. F. Innocenti, C. Grimsley, and S. Das Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups Pharmacogenetics 12 2002 725 733
33. R.C. Siow, H. Sato, and G.E. Mann Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res 41 1999 385 394
34. I. Rigato, J.D. Ostrow, and C. Tiribelli Bilirubin and the risk of common non-hepatic diseases Trends Mol Med 11 2005 277 283
35. B. Rantner, B. Kollerits, and M. Anderwald-Stadler Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study Clin Chem 54 2008 851 857
36. J.P. Lin, C.J. O'Donnell, and J.P. Schwaiger Association between the UGT1A128 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study Circulation 114 2006 1476 1481
37. T. Vera, J.P. Granger, and D.E. Stec Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates angiotensin-II dependent hypertension in mice Am J Physiol Regul Integr Comp Physiol 2009
38. J.P. Lin, J.P. Schwaiger, and L.A. Cupples Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels - The Framingham Heart Study Atherosclerosis 2009
39. H.A. Schwertner, and L. Vitek Gilbert syndrome, UGT1A128 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin Atherosclerosis 198 2008 1 11
40. M. Katoh, Y. Yoshioka, and N. Nakagawa Effects of Japanese herbal medicine, Kampo, on human UGT1A1 activity Drug Metab Pharmacokinet 24 2009 226 234
41. M.R. Saracino, J. Bigler, and Y. Schwarz Citrus fruit intake is associated with lower serum bilirubin concentration among women with the UGT1A128 polymorphism J Nutr 139 2009 555 560
42. J. Kapitulnik Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties Mol Pharmacol 66 2004 773 779
43. V. Gajdos, F.M. Petit, and C. Perret Further evidence that the UGT1A128 allele is not associated with coronary heart disease: The ECTIM Study Clin Chem 52 2006 2313 2314
44. Y. Duguay, M. McGrath, and J. Lepine The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk Cancer Res 64 2004 1202 1207
45. M. McGrath, J. Lepine, and I.M. Lee Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk Pharmacogenet Genomics 19 2009 239 243
46. V. Ribrag, S. Koscielny, and O. Casasnovas Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis Blood 113 2009 3307 3313
47. Z. Cheng, G.R. Rios, and C.D. King Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7 Toxicol Sci 45 1998 52 57
48. J.L. Fang, F.A. Beland, and D.R. Doerge Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes Cancer Res 62 2002 1978 1986
49. S. Kalthoff, U. Ehmer, and N. Freiberg Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10 J Biol Chem 285 2010 5993 6002
50. K.S. Tang, H.F. Chiu, and H.H. Chen Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes World J Gastroenterol 11 2005 3250 3254
51. C.P. Strassburg, A. Vogel, and S. Kneip Polymorphisms of the UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer Gut 50 2002 851 856
52. C. Guillemette, R.C. Millikan, and B. Newman Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans Cancer Res 60 2000 950 956
53. C. Guillemette, I. De Vivo, and S.E. Hankinson Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels Cancer Epidemiol Biomarkers Prev 10 2001 711 714
54. R. Sparks, C.M. Ulrich, and J. Bigler UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients Breast Cancer Res 6 2004 R488 R498
55. O.J. Adegoke, X.O. Shu, and Y.T. Gao Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer Breast Cancer Res Treat 85 2004 239 245
56. H.E. Wasmuth, H. Keppeler, and U. Herrmann Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis Hepatology 43 2006 738 741
57. N. Vasavda, S. Menzel, and S. Kondaveeti The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease Br J Haematol 138 2007 263 270
58. E.M. del Giudice, S. Perrotta, and B. Nobili Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis Blood 94 1999 2259 2262
59. S. Chouinard, M. Tessier, and G. Vernouillet Inactivation of the pure antiestrogen fulvestrant and other synthetic estrogen molecules by UGT1A enzymes expressed in the breast tissue Mol Pharmacol 2005
60. T. Ebner, R.P. Remmel, and B. Burchell Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol Mol Pharmacol 43 1993 649 654 (Pubitemid 23112743)
61. A. Ghosal, N. Hapangama, and Y. Yuan Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia) Drug Metab Dispos 32 2004 314 320 (Pubitemid 38263889)
62. C.D. King, G.R. Rios, and M.D. Green Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds Drug Metab Dispos 25 1997 251 255
63. G.E. Kuehl, J.W. Lampe, and J.D. Potter Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes Drug Metab Dispos 33 2005 1027 1035
64. B.W. Ogilvie, D. Zhang, and W. Li Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of cyp2c8: implications for drug-drug interactions Drug Metab Dispos 34 2006 191 197
65. T. Prueksaritanont, R. Subramanian, and X. Fang Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization Drug Metab Dispos 30 2002 505 512
66. K. Deterding, K. Grungreiff, and T.O. Lankisch Gilbert's syndrome and antiviral therapy of hepatitis C Ann Hepatol 8 2009 246 250
67. F. Innocenti, E.E. Vokes, and M.J. Ratain Irinogenetics: what is the right star? J Clin Oncol 24 2006 2221 2224
68. T.O. Lankisch, A. Vogel, and S. Eilermann Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene Mol Pharmacol 67 2005 1732 1739
69. Y. Ando, H. Saka, and G. Asai UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan Ann Oncol 9 1998 845 847
70. Y. Kawato, M. Aonuma, and Y. Hirota Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11 Cancer Res 51 1991 4187 4191
71. R.H. Tukey, C.P. Strassburg, and P.I. Mackenzie Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity Mol Pharmacol 62 2002 446 450
72. F. Innocenti, and M.J. Ratain Irinotecan treatment in cancer patients with UGT1A1 polymorphisms Oncology (Williston Park) 17 2003 52 55
73. J.Y. Douillard, D. Cunningham, and A.D. Roth Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 2000 1041 1047
74. J.F. Gagne, V. Montminy, and P. Belanger Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10- hydroxycamptothecin (SN-38) Mol Pharmacol 62 2002 608 617
75. F. Innocenti, S.D. Undevia, and L. Iyer Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan J Clin Oncol 22 2004 1382 1388 Epub 2004 Mar 1388
76. L. Iyer, C.D. King, and P.F. Whitington Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes J Clin Invest 101 1998 847 854
77. E. Marcuello, A. Altes, and A. Menoyo UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer Br J Cancer 91 2004 678 682
78. E. Rouits, M. Boisdron-Celle, and A. Dumont Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients Clin Cancer Res 10 2004 5151 5159
79. L.E. Carlini, N.J. Meropol, and J. Bever UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan Clin Cancer Res 11 2005 1226 1236
80. C.F. Stewart, J.C. Panetta, and M.A. O'Shaughnessy UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan J Clin Oncol 25 2007 2594 2600
81. M. Onoue, T. Terada, and M. Kobayashi UGT1A16 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients Int J Clin Oncol 14 2009 136 142
82. M. Ciotti, N. Basu, and M. Brangi Glucuronidation of 7-ethyl-10- hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus Biochem Biophys Res Commun 260 1999 199 202
83. C. Guillemette, J.K. Ritter, and D.J. Auyeung Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene Pharmacogenetics 10 2000 629 644
84. M.N. Tallman, K. Miles, and F. Kessler The contribution of intestinal Udp-glucuronosyltrasferases in modulating Sn-38 induced gastrointestinal toxicity in rats J Pharmacol Exp Ther 2006
85. T.O. Lankisch, C. Schulz, and T. Zwingers Gilbert's syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk Cancer Epidemiol Biomarkers Prev 17 2008 695 701
86. E. Cecchin, F. Innocenti, and M. D'Andrea Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan J Clin Oncol 27 2009 2457 2465
87. U. Ehmer, T.O. Lankisch, and T.J. Erichsen Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert's syndrome marker UGT1A128 J Mol Diagn 10 2008 549 552
88. S. Kalthoff, U. Ehmer, and N. Freiberg Coffee induces expression of glucuronosyltransferases via the aryl hydrocarbon receptor and Nrf2 in liver and stomach Gastroenterology 2010
89. M. Rotger, P. Taffe, and G. Bleiber Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia J Infect Dis 192 2005 1381 1386
90. S.D. Zucker, X. Qin, and S.D. Rouster Mechanism of indinavir-induced hyperbilirubinemia Proc Natl Acad Sci U S A 98 2001 12671 12676
91. D. Zhang, T.J. Chando, and D.W. Everett In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation Drug Metab Dispos 33 2005 1729 1739
92. T.O. Lankisch, U. Moebius, and M. Wehmeier Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype Hepatology 44 2006 1324 1332
93. T.O. Lankisch, G. Behrens, and U. Ehmer Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy - an extended haplotype of genetic variants increases risk in indinavir treatment J Hepatol 50 2009 1010 1018
94. R. Testa, E. Bardellini, and S. Borzone Caffeine clearance in subjects with constitutional unconjugated hyperbilirubinemia Ital J Gastroenterol 27 1995 129 132
95. E.V. Haverfield, C.A. McKenzie, and T. Forrester UGT1A1 variation and gallstone formation in sickle cell disease Blood 105 2005 968 972
96. G. Monaghan, M. Ryan, and R. Seddon Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome Lancet 347 1996 578 581
97. C.D. King, M.D. Green, and G.R. Rios The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP- glucuronosyltransferase 1.1 Arch Biochem Biophys 332 1996 92 100